Up Close with Lisocabtagene Maraleucel
Last Updated: September 24, 2026
Review lisocabtagene maraleucel indications, dosing, administration, monitoring, and key safety considerations.
Related Resources:
Find Similar Resources:
CAR-T
CAR-T
CAR-T
CAR-T
Outpatient CAR-T Toxicity and Rapid-Escalation Playbook
Last Updated: 09/15/2026
Outpatient CAR-T Program Readiness Assessment and Implementation Roadmap
Last Updated: 09/15/2026
Outpatient CAR-T Patient and Caregiver Eligibility, Education, and Monitoring Toolkit
Last Updated: 09/14/2026
Community Cancer Center Working with CAR-T Centers
Last Updated: 09/14/2026
Immunotherapy
Immunotherapy
Immunotherapy
Immunotherapy
Overview of BTCEs: Comparison of Bispecific T-Cell Engagers (BTCEs)
Last Updated: 09/09/2026
Up Close with Linvoseltamab
Last Updated: 06/29/2026
Example SOPs and Documents: Transitioning Patients on Bispecific T-Cell Engagers Between Care Settings
Last Updated: 07/01/2025
Example SOPs and Documents: Bispecific T-cell Engager Billing Procedure
Last Updated: 07/01/2025
PQI Podcast
PQI
Patient Education Sheet
Patient Education Sheet
S11 E12: Beyond Service: Supporting Veterans and Their Families Through Cancer Care
Last Updated: 11/12/2026
PQI: Beizray – An FDA-Approved Albumin Solubilized Formulation of Docetaxel
Last Updated: 11/02/2026
Vusolimogene Oderparepvec
Last Updated: 10/26/2026
Vusolimogene Oderparepvec and Nivolumab
Last Updated: 10/26/2026